Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).
about
Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease.Discovery and development of clofarabine: a nucleoside analogue for treating cancer.Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.Nucleoside transporters in chronic lymphocytic leukaemia.Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates.The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs.Troxacitabine in leukemia.Genetic factors influencing cytarabine therapy.Human nucleoside transporters: biomarkers for response to nucleoside drugs.Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variant.Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer.Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicity.Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry.Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine.
P2860
Q34155353-E40B522F-3F2E-4667-A35B-27F6402301CDQ34571029-CB703514-C95D-4D0E-848E-8065EFE6E7CCQ35567292-F41C70D6-1D81-4360-8B73-3DC652E09F9FQ35635321-8F811927-5C82-48E1-AA2C-E39D4A878BECQ36728158-F456D3D7-407D-48C4-BA63-128921C956A1Q36754229-0AE46937-A31A-4767-AEFD-215A26756D4CQ36868592-D66C45B8-842F-4BCC-8377-A15AE397A4C3Q37618228-D12FB466-1102-497B-8FA0-88A8A2C05E3FQ37698437-3097F033-51FB-43B9-8580-4AEFEE4818D5Q40342848-A4F3F450-E5AE-463B-80E1-AF949C97ADACQ40506711-C93E6BDA-691F-427C-A60A-0FB34D52F698Q43191335-554DB17A-145B-4B35-9B92-4F33E6AAF9A7Q44204619-73471E79-0237-4CEB-9331-6A932675B866Q45141158-E8AEA3D6-4230-48B9-A1C4-846EE7600C6BQ48655141-9CC1CAC7-F8D8-4B89-98E4-C7761081B8B3
P2860
Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Es nucleoside transporter cont ...... sitivity to cytarabine (araC).
@ast
Es nucleoside transporter cont ...... sitivity to cytarabine (araC).
@en
Es nucleoside transporter cont ...... cell sensitivity to cytarabine
@nl
type
label
Es nucleoside transporter cont ...... sitivity to cytarabine (araC).
@ast
Es nucleoside transporter cont ...... sitivity to cytarabine (araC).
@en
Es nucleoside transporter cont ...... cell sensitivity to cytarabine
@nl
prefLabel
Es nucleoside transporter cont ...... sitivity to cytarabine (araC).
@ast
Es nucleoside transporter cont ...... sitivity to cytarabine (araC).
@en
Es nucleoside transporter cont ...... cell sensitivity to cytarabine
@nl
P2093
P2860
P1433
P1476
Es nucleoside transporter cont ...... sitivity to cytarabine (araC).
@en
P2093
Chlumecky V
Larratt LM
Paterson AR
P2860
P356
10.3109/10428199809059245
P577
1998-12-01T00:00:00Z